Contact Us to find out how Model Answers can help you plan the optimal use of PK-PD analysis, modelling and simulation in the drug development life cycle.
Choosing the optimal number of doses or how many subjects to enroll in a clinical trial is critical to understanding the dose/exposure-response relationship.
Contact Us to find out how Model Answers can help you plan the optimal use of PK-PD analysis, modelling and simulation in the drug development life cycle.